Sandoz

CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Thu, 03/14/19 - 10:06 am
Novartis
Sandoz
generics
M&A
Richard Francis
biosimilars
Indivior introduces generic version of Suboxone opioid drug in US
Pharmaceutical Business Review
Thu, 02/21/19 - 09:56 am
Indivior
Sandoz
generics
opioids
Suboxone Film
‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts
Fierce Pharma
Fri, 02/1/19 - 10:33 pm
Novartis
Sandoz
layoffs
drug manufacturing
Novartis plots new course for Sandoz
BioCentury
Wed, 01/30/19 - 11:43 pm
Novartis
Sandoz
generics
UnitedHealthcare, fueled by federal probes, sues generics makers for price fixing
Fierce Pharma
Tue, 01/22/19 - 11:48 am
UnitedHealthcare
generics
price fixing
drug pricing
Mylan
Teva Pharmaceuticals
Sandoz
Actavis
Par Pharmaceutical
Sun Pharma
Aurobindo
Taro Pharmaceuticals
Sandoz launches EpiPen rival at $250 per two-pack
BioPharma Dive
Fri, 01/18/19 - 09:21 pm
Sandoz
Novartis
EpiPens
Symjepi
Adamis stock surges on release of EpiPen alternative
Marketwatch
Thu, 01/17/19 - 09:34 am
Adamis
Mylan
Sandoz
EpiPens
Symjepi
Novartis unit teams up with medical marijuana producer, marking milestone for pharma
Stat
Tue, 12/18/18 - 12:53 pm
Novartis
Sandoz
Medical Marijuana
Tilray Canada
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:37 pm
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Pear, Sandoz launch first FDA-approved digital therapeutic
BioCentury
Wed, 11/21/18 - 10:00 am
Pear Therapeutics
Sandoz
digital therapeutics
substance abuse
reSET
Novartis 'completely committed' to Sandoz, has no split-off plan
Yahoo/Reuters
Thu, 11/15/18 - 11:20 am
Novartis
Sandoz
generics
Novartis' Sandoz calls it quits on Rituxan biosimilar after FDA requests more data
Fierce Pharma
Mon, 11/5/18 - 11:53 am
Novartis
Sandoz
FDA
biosimilars
Roche
Rituxan
Novartis abandons effort for U.S. approval of biosimilar rituximab
Yahoo/Reuters
Sat, 11/3/18 - 12:39 pm
Novartis
Sandoz
rituximab
biosimilars
Roche
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Fri, 10/12/18 - 10:24 am
Novartis
Sandoz
AbbVie
Humira
biosimilars
Europe
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Biopharma Dive
Thu, 09/13/18 - 11:19 pm
Amgen
Sandoz
Enbrel
biosimilars
Novartis
Novartis sells parts of Sandoz for $1bn
Pharmaforum
Thu, 09/6/18 - 09:40 am
Novartis
Sandoz
M&A
dermatology
Aurobindo
Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Thu, 07/26/18 - 11:24 am
Omeros
Sandoz
Novartis
patents
Omidria
Omeros Prevails in Patent Dispute With Sandoz
Thu, 07/26/18 - 09:12 am
Omeros
Omidria
Sandoz
lawsuits
patent lawsuits
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Mon, 07/2/18 - 09:27 am
Adamis Pharmaceuticals
Novartis
Sandoz
Symjepi
Mylan
EpiPens

Pages